Literature DB >> 25194171

Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure.

Tal Hasin1, Sudhir S Kushwaha2, Timothy G Lesnick3, Walter Kremers3, Barry A Boilson2, John A Schirger2, Alfredo L Clavell2, Richard J Rodeheffer2, Robert P Frantz2, Brooks S Edwards2, Naveen L Pereira2, John M Stulak4, Lyle Joyce4, Richard Daly4, Soon J Park4, Allan S Jaffe5.   

Abstract

Left ventricular assist devices (LVADs) acutely decrease left ventricular wall stress. Thus, early postoperative levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) should decrease. This study investigated postoperative changes in NT-proBNP levels, the parameters related to changes, and the possible association with complications by performing a retrospective analysis of changes in daily NT-proBNP (pg/ml) levels from admission to discharge both before and after LVAD implantation in a tertiary referral center. For 72 patients implanted with HeartMate II LVADs, baseline NT-proBNP levels were elevated at 3,943 ng/ml (interquartile range 1,956 to 12,964). Preoperative stabilization led to marked decreases in NT-proBNP. Levels peaked 3 days after surgery and subsequently decreased. Patients with complicated postoperative courses had higher early postoperative elevations. By discharge, NT-proBNP decreased markedly but was still 2.83 (1.60 to 5.76) times the age-based upper limit of normal. The 26% reduction in NT-proBNP between admission and discharge was due mostly to the preoperative reductions and not those induced by the LVAD itself. The decrease was not associated with decreases in LV volume. In conclusion, preoperative treatment reduces NT-proBNP values. The magnitude of early postoperative changes is related to the clinical course. Levels at discharge remain markedly elevated and similar to values after preoperative stabilization despite presumptive acute LV unloading.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25194171     DOI: 10.1016/j.amjcard.2014.07.056

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.

Authors:  Shweta R Motiwala; Hanna K Gaggin
Journal:  Curr Heart Fail Rep       Date:  2016-10

2.  Dynamics and prognostic value of B-type natriuretic peptide in left ventricular assist device recipients.

Authors:  Maria Papathanasiou; Nikolaus Pizanis; Loukas Tsourelis; Achim Koch; Markus Kamler; Tienush Rassaf; Peter Luedike
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

3.  Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review.

Authors:  Eva Janssen; J Wouter Jukema; Saskia L M A Beeres; Martin J Schalij; Laurens F Tops
Journal:  Front Cardiovasc Med       Date:  2021-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.